Tower Bridge Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.24M Sell
35,251
-684
-2% -$79K 0.41% 67
2025
Q4
$3.78M Sell
35,935
-48
-0.1% -$4.51K 0.38% 65
2025
Q3
$3.02M Sell
35,983
-3,310
-8% -$273K 0.3% 75
2025
Q2
$3.11M Sell
39,293
-4,573
-10% -$364K 0.33% 75
2025
Q1
$3.94M Sell
43,866
-4,200
-9% -$392K 0.44% 66
2024
Q4
$4.78M Sell
48,066
-434
-0.9% -$44.7K 0.51% 54
2024
Q3
$5.51M Buy
48,500
+1,405
+3% +$167K 0.57% 51
2024
Q2
$5.83M Sell
47,095
-1,062
-2% -$137K 0.65% 46
2024
Q1
$6.35M Sell
48,157
-499
-1% -$61.5K 0.65% 48
2023
Q4
$5.3M Sell
48,656
-697
-1% -$72.3K 0.46% 64
2023
Q3
$5.08M Sell
49,353
-1,247
-2% -$134K 0.47% 64
2023
Q2
$5.84M Sell
50,600
-14,356
-22% -$1.63M 0.54% 56
2023
Q1
$6.91M Buy
64,956
+1,500
+2% +$162K 0.57% 58
2022
Q4
$7.04M Sell
63,456
-217
-0.3% -$22.2K 0.58% 51
2022
Q3
$5.48M Sell
63,673
-630
-1% -$56.2K 0.49% 64
2022
Q2
$5.86M Buy
64,303
+518
+0.8% +$45.9K 0.48% 66
2022
Q1
$5.23M Buy
63,785
+444
+0.7% +$35K 0.35% 78
2021
Q4
$4.85M Sell
63,341
-1,279
-2% -$102K 0.3% 84
2021
Q3
$4.85M Sell
64,620
-135
-0.2% -$10.3K 0.32% 81
2021
Q2
$5.04M Sell
64,755
-3,402
-5% -$253K 0.34% 80
2021
Q1
$5.01M Sell
68,157
-1,355
-2% -$100K 0.38% 77
2020
Q4
$5.43M Buy
69,512
+27,301
+65% +$2.09M 0.44% 65
2020
Q3
$3.34M Buy
42,211
+283
+0.7% +$22.2K 0.34% 75
2020
Q2
$3.09M Sell
41,928
-3,040
-7% -$229K 0.35% 69
2020
Q1
$3.3M Buy
44,968
+3,033
+7% +$238K 0.43% 67
2019
Q4
$3.64M Sell
41,935
-2,473
-6% -$203K 0.38% 77
2019
Q3
$3.54M Sell
44,408
-1,828
-4% -$147K 0.39% 74
2019
Q2
$3.7M Sell
46,236
-440
-0.9% -$33.7K 0.41% 71
2019
Q1
$3.7M Sell
46,676
-246
-0.5% -$18.4K 0.43% 69
2018
Q4
$3.42M Sell
46,922
-4,357
-8% -$308K 0.44% 70
2018
Q3
$3.47M Sell
51,279
-3,582
-7% -$228K 0.36% 78
2018
Q2
$3.18M Sell
54,861
-15,444
-22% -$871K 0.35% 79
2018
Q1
$3.65M Sell
70,305
-39,786
-36% -$2.15M 0.41% 74
2017
Q4
$5.91M Sell
110,091
-17,399
-14% -$965K 0.63% 59
2017
Q3
$7.79M Buy
127,490
+3,505
+3% +$212K 0.89% 45
2017
Q2
$7.58M Buy
123,985
+1,581
+1% +$96.2K 0.87% 48
2017
Q1
$7.42M Sell
122,404
-247
-0.2% -$15K 0.87% 45
2016
Q4
$6.89M Buy
122,651
+613
+0.5% +$35.9K 0.84% 47
2016
Q3
$7.27M Buy
122,038
+428
+0.4% +$25K 0.88% 42
2016
Q2
$6.69M Sell
121,610
-3,201
-3% -$170K 0.83% 43
2016
Q1
$6.3M Buy
124,811
+9,391
+8% +$460K 0.79% 49
2015
Q4
$5.82M Sell
115,420
-31,895
-22% -$1.61M 0.76% 49
2015
Q3
$6.94M Buy
147,315
+2,939
+2% +$156K 0.96% 42
2015
Q2
$7.84M Buy
144,376
+8,167
+6% +$458K 0.99% 42
2015
Q1
$7.47M Buy
136,209
+47,173
+53% +$2.67M 0.95% 45
2014
Q4
$4.82M Buy
89,036
+6,678
+8% +$372K 0.59% 62
2014
Q3
$4.66M Sell
82,358
-1,258
-2% -$70.6K 0.59% 59
2014
Q2
$4.62M Buy
83,616
+1,179
+1% +$64.3K 0.57% 61
2014
Q1
$4.47M Buy
82,437
+711
+0.9% +$36.8K 0.57% 58
2013
Q4
$3.9M Sell
81,726
-347
-0.4% -$15.9K 0.51% 62
2013
Q3
$3.73M Buy
82,073
+5,358
+7% +$245K 0.53% 64
2013
Q2
$3.4M Buy
+76,715
New +$3.43M 0.5% 63

Other funds holding MRK

Tower Bridge Advisors's MRK Position: Q1 2026 in Review

Tower Bridge Advisors reduced its Merck (MRK) stake by 1.9% in Q1 2026, selling an estimated $79K and leaving 35,251 shares worth $4.24M. The position accounts for 0.41% of the portfolio, ranked #67.

Tower Bridge Advisors first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $7.84M in Q2 2015. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Tower Bridge Advisors held 35,251 shares of Merck worth $4.24M as of Q1 2026.
  • Tower Bridge Advisors sold 684 Merck shares in Q1 2026, an estimated $79K.
  • Merck made up 0.41% of Tower Bridge Advisors's portfolio in Q1 2026, its #67 holding.
  • Tower Bridge Advisors first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • Tower Bridge Advisors's Merck position peaked at $7.84M in Q2 2015.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Tower Bridge Advisors's 13F filing for Q1 2026, filed 12 May 2026.